Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
06/1999
06/29/1999US5916873 Bactericides; grampositive bacteria
06/29/1999US5916872 Efficiency; long half-life
06/29/1999US5916768 Contraceptive vaccine based on alloimmunization with zona pellucida polypeptides
06/29/1999US5916558 Recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypeptides and peptides in the diagnostic of tuberculosis
06/24/1999WO1999031126A1 Cyclopeptide derivatives with integrin inhibitor properties
06/24/1999WO1999031125A1 Wound healing compositions
06/24/1999WO1999031123A1 Antifungal and antibacterial peptides
06/24/1999WO1999030732A1 Gamma-conopeptides
06/24/1999WO1999007728A3 Linear peptides derived from antibiotic peptides, preparation and use for vectoring active substances
06/24/1999CA2315250A1 Antifungal and antibacterial peptides
06/24/1999CA2314686A1 Gamma-conopeptides
06/23/1999EP0923645A1 Insect neuropeptides genes and peptides
06/23/1999EP0923605A1 Conjugated mucin peptide vaccines
06/23/1999EP0923604A1 Cysteine-containing or methioine-containing peptides with immunomodulatory effects
06/23/1999EP0923601A2 Librairies of backbone-cyclized peptidomimetics
06/23/1999CN1220670A Inhibitor and stimulator of stem cell proliferationa and use thereof
06/22/1999US5914319 Antithrombotic agents
06/22/1999US5914317 A dna which hybridizes under high stringency conditions to a preferential dna sequence encodes b1k proteins which contains atleast thirty amino acid residues in length; useful for treating dermis disorder such as epidermal bulosis
06/22/1999US5914313 Antibiotics
06/19/1999CA2237051A1 Enhanced affinity hyaluronan binding peptides
06/19/1999CA2225326A1 A simple and efficient method to prepare technetium-99m labelled peptides
06/17/1999WO1999029716A1 Echinocandin derivatives, preparation method and application as anti-fungal agents
06/17/1999WO1999029714A2 Organic chemical compounds and method for producing the same
06/17/1999WO1999015549A3 Peptide sequences as hinge regions in proteins like immunoglobulin fragments and their use in medicine
06/17/1999WO1998056919A3 Methods and reagents for vaccination which generate a cd8 t cell immune response
06/17/1999WO1998018823A8 Ice inhibiting peptides
06/17/1999DE19755800A1 Cyclopeptidderivate Cyclopeptide derivatives
06/17/1999CA2311295A1 Echinocandin derivatives, preparation method and application as anti-fungal agents
06/16/1999EP0922958A2 Interference reduction in diagnostic methods using D-amino acid peptides
06/16/1999EP0922059A1 Monoclonal antibodies that define unique meningococcal b epitopes and their use in the preparation of vaccine compositions
06/16/1999EP0921808A1 Non-aqueous polar aprotic peptide formulations
06/16/1999EP0491828B1 PEPTIDES FROM GTPase-ACTIVATING PROTEIN (GAP), DIAGNOSTIC AND THERAPEUTIC USE THEREOF
06/16/1999CN1219938A Conjugates of lipophilic moieties and fragments of vasoactive intestinal peptide (VIP)
06/15/1999US5912226 Antibiotic
06/15/1999US5912183 Amino acid sequences with phosphorylated tyrosine which interact with intracellular signal transducers and interfere with signal transduction; antimetastasis/anticarcinogenic/ antitumor/antiproliferative agents
06/15/1999US5912177 Stem cell immobilization
06/15/1999US5912131 Peptides produced by digestion of bone collagen with protease and purified to contain a 3-hydroxypyridinium crosslink; also bind to monoclonal antibody 1h11
06/10/1999WO1999028345A1 Conjugates useful in the treatment of prostate cancer
06/10/1999WO1999028338A1 Inhibition of nuclear import by backbone cyclic peptide analogs
06/10/1999WO1999027958A2 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination
06/10/1999WO1999027945A1 Threonine-containing protegrins
06/10/1999WO1999012958A3 Ampullosporin, method for producing same and its use
06/10/1999WO1998004582A8 Isolated peptides derived from mage-2
06/10/1999DE19754298A1 Organisch-chemische Verbindungen und Verfahren zu ihrer Herstellung Organic chemical compounds and methods for their preparation
06/10/1999CA2312191A1 Threonine-containing protegrins
06/10/1999CA2311768A1 Inhibition of nuclear import by backbone cyclic peptide analogs
06/10/1999CA2311647A1 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination
06/10/1999CA2311615A1 Conjugates useful in the treatment of prostate cancer
06/09/1999EP0920510A1 GnRH-LEUKOTOXIN CHIMERAS
06/09/1999EP0920453A1 Fluorescent peptides
06/09/1999EP0920451A1 Novel peptides suitable for use in antigen specific immunosuppressive therapy
06/09/1999EP0920448A1 Truncated glial cell line-derived neurotrophic factor
06/09/1999EP0920447A1 Process of purification of cyclosporin
06/09/1999EP0920446A1 Conformationally constrained backbone cyclized somatostatin analogs
06/09/1999EP0920324A2 Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections
06/09/1999EP0661986B1 Brain-enhanced delivery of neuroactive peptides by sequential metabolism
06/09/1999EP0620740B1 Injectable lecithin gel
06/09/1999CN1219240A Purification of tissue plasminogen activator
06/09/1999CN1219175A Zona pellucida proteins for contraception
06/08/1999US5910568 Molecule involved in binding of sperm to egg surfaces and procedures for use of this molecule to enhance or decrease potential fertility
06/08/1999US5910565 Oligoglycine compound, fibrous microtube of oligoglycine compound and process of producing fibrous microtube
06/08/1999US5910478 Peptidomimetics inhibiting the oncogenic action of p21 ras
06/08/1999US5910451 Trophinin and trophinin-assisting proteins
06/08/1999US5910428 Dna which codes for corticotropin-releasing factor binding protein; treating of eating disorders, alcholism; hypertensive agents
06/08/1999US5910404 Amino acid sequence of peptide mimetic; for screening blood and blood products; use as immunogens
06/03/1999WO1999027366A2 Method of detecting prostate specific antigen activation peptide
06/03/1999WO1999027138A1 Nucleic acid ligands of tissue target
06/03/1999WO1999026968A1 Oligopeptides and their use as antibacterial agents against staphylococcus strains
06/03/1999WO1999026965A1 Cyclosporine derivatives and uses thereof
06/03/1999WO1999026964A1 LIQUID PHASE PROCESS FOR THE PREPARATION OF GnRH PEPTIDES
06/03/1999WO1999026963A1 Hypusine peptides
06/03/1999WO1999026644A1 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
06/03/1999WO1999013907A3 Methods to improve immunogenicity of antigens and specificity of antibodies
06/03/1999WO1999007729A3 Peptides having potassium channel opener activity
06/03/1999CA2311164A1 Nucleic acid ligands of tissue target
06/03/1999CA2310852A1 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
06/03/1999CA2310777A1 Method of detecting prostate specific antigen
06/03/1999CA2310027A1 Hypusine peptides
06/02/1999EP0919567A1 Novel peptides and nootropic agent
06/02/1999EP0919566A2 Antimicrobial peptides and their use against plant pathogens
06/02/1999EP0918795A1 Antiangiogenic drug to treat cancer, arthritis and retinopathy
06/02/1999EP0918793A1 Inactivating process for lipid envelopped virus, and new antivirus lipopeptides
06/02/1999EP0918547A2 Radiolabeled annexins
06/02/1999EP0680513B1 Lysosomal targeting of immunogens
06/02/1999CN1218507A Deacylation of cyclic lipopetides
06/02/1999CN1218478A Cyclic adhesion inhibitors
06/02/1999CN1218406A HLA-A2.1 binding peptides and their uses
06/01/1999US5908832 Peptide analog
06/01/1999CA1340577C Recombinant systems for expressions of cholera b-subunit with the aid of foreign promoters and/or leader peptides
05/1999
05/27/1999WO1999025731A1 Cyclic peptides and medicinal use thereof
05/27/1999WO1999025729A1 Compounds with antitumor activity
05/27/1999WO1999025728A1 Novel exendin agonist compounds
05/27/1999WO1999025381A1 Linear antigen supporting units
05/27/1999WO1999025379A1 Modified antibodies with enhanced ability to elicit an anti-idiotype response
05/27/1999WO1999025378A1 Immunoglobulin molecules having a synthetic variable region and modified specificity
05/27/1999WO1999025372A1 Small peptides and methods for treatment of asthma and inflammation
05/27/1999CA2310462A1 Linear antigen supporting units
05/27/1999CA2310269A1 Immunoglobulin molecules having a synthetic variable region and modified specificity
05/27/1999CA2309990A1 Modified antibodies with enhanced ability to elicit an anti-idiotype response
05/27/1999CA2278030A1 Cyclic peptides and medicinal use thereof
1 ... 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 ... 423